Medicine
Yale study finds low levels of a hormone may predict long COVID
Yale and Icahn School of Medicine researchers may have found biomarkers for identifying long COVID.
Only human Lyme vaccine in development enters phase 3 trial
Pfizer and French biotech Valneva have announced a phase 3 clinical trial testing the human Lyme vaccine.
Half of all vaccines are wasted. A gel could save them.
A new hydrogel that wraps around heat-sensitive molecules could help prevent vaccine waste by keeping them viable at higher temperatures.
What ever happened to the first cryogenically frozen humans?
For decades, people have arranged to freeze their bodies after death, dreaming of resurrection by advanced future medicine.
A new drug could repair stroke damage to memory and movement
A new drug can repair stroke damage in mice, improving memory and motor skills. If it works in humans, it could lead to a paradigm shift in stroke treatment.
Long COVID-19 and chronic conditions after viral infections may stem from an overactive immune response
Understanding the immunological mechanisms underlying long COVID-19 is the first step to addressing a quickly worsening public health problem.
Why don't surgeons train like fighter pilots? Now some do.
Using AI and analysis, Theator is helping surgeons improve how pilots and pro athletes do: by going to the tape.
The Biden administration is preparing for legal psychedelics within two years
The Biden administration’s Department of Health and Human Services has sent a memo supportive of psychedelic therapies. What does that mean for the field?
ADHD drugs might also treat Alzheimer’s disease
Scientists reviewed 40 years of clinical studies that assessed the effects of NA-targeting drugs, such as certain ADHD drugs, on Alzheimer’s.
A cheap nasal spray cuts COVID-19 risk by 62%
A low-cost nasal spray co-developed by Oxford researchers could be the next powerful weapon against COVID-19.